Anastrozole Tablet
Product Images NDC 16729-035

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 16729-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle (Anastrozole 1mg 30 Label)

Bottle (Anastrozole 1mg 30 Label)
Anastrozole is a medication that comes in the form of tablets. Each tablet contains 1mg of Anastrozole USP. The recommended dosage information can be found in the Professional Information Brochure that accompanies the medication. This medication should be kept out of the reach of children, stored in a tight container at controlled room temperature (between 77-88°F). The manufacturer is Accord Healthcare, Inc. located in Durham, NC. The tablets are manufactured by Intas Pharmaceuticals Limited located in Ahmedabad, India. The tablets are only available through a prescription by a pharmacist with a patient information leaflet. The packaging contains 30 tablets. No other information is available.*
FDA Label Image

Figure 1 (Anastrozole Fig1)

Figure 1 (Anastrozole Fig1)
FDA Label Image

Figure 2 (Anastrozole Fig2)

Figure 2 (Anastrozole Fig2)
FDA Label Image

Figure 3 (Anastrozole Fig3)

Figure 3 (Anastrozole Fig3)
FDA Label Image

Figure 4 (Anastrozole Fig4)

Figure 4 (Anastrozole Fig4)
FDA Label Image

Figure 5 (Anastrozole Fig5)

Figure 5 (Anastrozole Fig5)
This text seems to be showing the results of a randomized treatment study comparing the effectiveness of Anastrozole to Tamoxifen in stopping the progression of FFOPORTICK, which is not a recognizable medical condition. The table appears to show the number of patients who progressed in each treatment group at different time points. However, without more context and readable text, it is difficult to provide a more specific description.*
FDA Label Image

Figure 6 (Anastrozole Fig6)

Figure 6 (Anastrozole Fig6)
FDA Label Image

Chemical Structure For Anastrozole (Anastrozole Str)

Chemical Structure For Anastrozole (Anastrozole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.